Key facts
- ScribePro Team’s last known valuation is $3.5M (Jul 2025).
- It has raised $750K; the latest was Angel (individual) ($270K) in Jul 2025.
- Notable investors include Gordon MacKay, Steven Naismith.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for ScribePro Team
- ·The full record, as it builds
Funding rounds
No funding rounds for ScribePro Team are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ScribePro Team
Developer of a digital medical record-keeping platform designed for improved patient care delivery. The company's platform offers a secure, real-time system for clinicians to record, manage, and analyze medical interactions through web and mobile applications, providing tailored injury reports and predictive data models, enabling sports and event medicine practitioners and organizations to streamline medical documentation and enhance athlete well-being.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2018
- Employees
- 8
- Website
- scribepro.co/
- Ownership
- Privately Held (backing)
ScribePro Team doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ScribePro Team shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ScribePro Team in its N-PORT filings yet. We sweep new filings monthly.